A PHASE-I CLINICAL TOLERANCE STUDY OF RDNA ALPHA2 HUMAN INTERFERON IN PATIENTS WITH NON-RETICULOENDOTHELIAL SYSTEM MALIGNANCIES

被引：15

作者：

EDELSTEIN, MB

SCHELLEKENS, H

LAURENT, T

GAUCI, L

机构：

[1] ACAD ZIEKENHUIS LEIDEN,2333 AA LEIDEN,NETHERLANDS

[2] SCHERING PLOUGH CO,F-69572 DARDILLY,FRANCE

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1983年 / 19卷 / 07期

关键词：

D O I：

10.1016/0277-5379(83)90053-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：891 / 894

页数：4

共 20 条

[1]

BARON S, 1977, INTERFERON SYSTEMS C, V39

[2]

BLANCHETBARDON C, 1981, LANCET, V1, P174

[3] INTERFERONS - RATIONALE FOR CLINICAL-TRIALS IN NEOPLASTIC DISEASE [J].

BORDEN, EC .

ANNALS OF INTERNAL MEDICINE, 1979, 91 (03) :472-479

[4]

Chamberlain EN, 1961, SYMPTOMS SIGNS CLIN

[5]

EDELSTEIN M, 1983, P AM ASS CANCER RES

[6]

FRIEDMAN RM, 1981, INTERFERONS PRIMER

[7] HUMAN-LEUKOCYTE INTERFERON PRODUCED BY ESCHERICHIA-COLI IS BIOLOGICALLY-ACTIVE [J].

GOEDDEL, DV ;

YELVERTON, E ;

ULLRICH, A ;

HEYNEKER, HL ;

MIOZZARI, G ;

HOLMES, W ;

SEEBURG, PH ;

DULL, T ;

MAY, L ;

STEBBING, N ;

CREA, R ;

MAEDA, S ;

MCCANDLISS, R ;

SLOMA, A ;

TABOR, JM ;

GROSS, M ;

FAMILLETTI, PC ;

PESTKA, S .

NATURE, 1980, 287 (5781) :411-416

[8] ANTI-TUMOR EFFECTS OF INTERFERON [J].

GRESSER, I ;

TOVEY, MG .

BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 516 (02) :231-247

[9] RECOMBINANT LEUKOCYTE-A INTERFERON - PHARMACOKINETICS, SINGLE-DOSE TOLERANCE, AND BIOLOGIC EFFECTS IN CANCER-PATIENTS [J].

GUTTERMAN, JU ;

FINE, S ;

QUESADA, J ;

HORNING, SJ ;

LEVINE, JF ;

ALEXANIAN, R ;

BERNHARDT, L ;

KRAMER, M ;

SPIEGEL, H ;

COLBURN, W ;

TROWN, P ;

MERIGAN, T ;

DZIEWANOWSKI, Z .

ANNALS OF INTERNAL MEDICINE, 1982, 96 (05) :549-556

[10] CLINICAL AND IMMUNOLOGICAL EFFECTS OF RECOMBINANT LEUKOCYTE A INTERFERON IN 8 PATIENTS WITH ADVANCED CANCER [J].

HORNING, SJ ;

LEVINE, JF ;

MILLER, RA ;

ROSENBERG, SA ;

MERIGAN, TC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (12) :1718-1722

← 1 2 →